Clay B. Frederick - Publications, H-index & Citations

Clay B. Frederick

merck & company

20H指数

63论文数

1.4K被引数

收录论文 13

发表时间

Reader comment on: Comprehensive genotoxicity and carcinogenicity assessment of molnupiravir

TOXICOLOGICAL SCIENCES

IF4.1

2024-12-18

PREAI

Frederick, Clay B.; Schinazi, Raymond F.; Swanstrom, Ronald

Native Oxyntomodulin Has Significant Glucoregulatory Effects Independent of Weight Loss in Obese Humans With and Without Type 2 Diabetes

DIABETES

IF7.5

2018-03-15

OAAI

Shankar, Sudha S.; Shankar, R. Ravi; Mixson, Lori A.; Miller, Deborah L.; Pramanik, Barnali; O'Dowd, Amy K.; Williams, Donna M.; Frederick, Clay B.; Beals, Chan R.; Stoch, S. Aubrey; Steinberg, Helmut O.; Kelley, David E.

Characterization of the Exocrine Pancreas in the Male Zucker Diabetic Fatty Rat Model of Type 2 Diabetes Mellitus Following 3 Months of Treatment With Sitagliptin

ENDOCRINOLOGY

IF3.3

2014-03-01

OAAI

Forest, Thomas; Holder, Daniel; Smith, Adam; Cunningham, Caron; Yao, Xiaorui; Dey, Markus; Frederick, Clay; Prahalada, Srinivasa

Metabolites in Safety Testing: MIST for the Clinical Pharmacologist

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

2010-01-27

PREAI

Frederick, C. B.; Obach, R. S.

Safety Assessment of Drug Metabolites: Implications of Regulatory Guidance and Potential Application of Genetically Engineered Mouse Models that Express Human P450s

CHEMICAL RESEARCH IN TOXICOLOGY

IF3.8

2009-01-26

PREAI

Powley, Mark W.; Frederick, Clay B.; Sistare, Frank D.; DeGeorge, Joseph J.

CYP2C75-involved autoinduction of metabolism in rhesus monkeys of methyl 3-chloro-3′-fluoro-4′-{(1R)-1-[({1-[(trifluoroacetyl)amino]cyclopropyl}carbonyl)amino]ethyl}-1,1′-biphenyl-2-carboxylate (MK-0686), a bradykinin B1 receptor antagonist

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

IF3.8

2008-06-01

PREAI

Tang, Cuyue; Carr, Brian A.; Poignant, Frederic; Ma, Bennett; Polsky-Fisher, Stacey L.; Kuo, Yuhsin; Strong-Basalyga, Kristie; Norcross, Alisha; Richards, Karen; Eisenhandler, Roy; Carlini, Edward J.; Di Marco, Christina Ng; Kuduk, Scott D.; Yu, Nathan X.; Raab, Conrad E.; Rushmore, Tom; Frederick, Clay B.; Bock, Mark G.; Prueksaritanont, Thomayant

Skin irritation, basal epithelial cell proliferation, and carcinogenicity evaluations of a representative specialty acrylate and methacrylate

REGULATORY TOXICOLOGY AND PHARMACOLOGY

IF3.5

2003-02-01

PREAI

Van Miller, JP; Garman, RH; Hermansky, SJ; Mirsalis, JC; Frederick, CB

Physiologically based pharmacokinetic (PBPK) models for nasal tissue dosimetry of organic esters: Assessing the state-of-knowledge and risk assessment applications with methyl methacrylate and vinyl acetate

REGULATORY TOXICOLOGY AND PHARMACOLOGY

IF3.5

2002-12-01

PREAI

Andersen, ME; Green, T; Frederick, CB; Bogdanffy, MS

Use of a hybrid computational fluid dynamics and physiologically based inhalation model for interspecies dosimetry comparisons of ester vapors

TOXICOLOGY AND APPLIED PHARMACOLOGY

IF3.4

2002-08-01

PREAI

Frederick, CB; Lomax, LG; Black, KA; Finch, L; Scribner, HE; Kimbell, JS; Morgan, KT; Subramaniam, RP; Morris, JB

Improving risk assessment: Toxicological research needs

HUMAN AND ECOLOGICAL RISK ASSESSMENT

IF2.7

2002-05-01

PREAI

Toraason, M; Andersen, M; Bogdanffy, MS; Dankovic, D; Faustman, E; Foster, P; Frederick, C; Haber, L; Kimmel, CA; Lewis, S; McClellan, R; Melnick, R; Mirer, F; Morgan, K; Schaeffer, V; Silbergeld, E; Slikker, W; Swenberg, J; Vainio, H

Untitled

TOXICOLOGY AND APPLIED PHARMACOLOGY

IF3.4

1998-11-01

PREAI

Andersen, M; Brusick, D; Cohen, S; Dragan, Y; Frederick, C; Goodman, JI; Hard, G; Meek, B; O'Flaherty, EJ

Application of a hybrid computational fluid dynamics and physiologically based inhalation model for interspecies dosimetry extrapolation of acidic vapors in the upper airways

TOXICOLOGY AND APPLIED PHARMACOLOGY

IF3.4

1998-09-01

106

PREAI